Demonstration of the weighted-incidence syndromic combination antibiogram: An empiric prescribing decision aid

Infection Control and Hospital Epidemiology

Volumn 33, Issue 4, 2012, Pages 381-388

  Hebert, Courtney ^a   Ridgway, Jessica ^b   Vekhter, Benjamin ^c   Brown, Eric C ^d   Weber, Stephen G ^b,c   Robicsek, Ari ^c,d  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; MACROLIDE; MEROPENEM; MEROPENEM PLUS VANCOMYCIN; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BETA HEMOLYTIC STREPTOCOCCUS; BILIARY TRACT INFECTION; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; ENTEROBACTERIACEAE; ENTEROCOCCUS; FEMALE; GRAM NEGATIVE ANAEROBIC BACTERIA; GRAM POSITIVE BACTERIUM; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTION; WEIGHTED INCIDENCE SYNDROMIC COMBINATION ANTIBIOGRAM;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHICAGO; DECISION SUPPORT TECHNIQUES; DELIVERY OF HEALTH CARE; DRUG PRESCRIPTIONS; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; INFECTION; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; URINARY TRACT INFECTIONS;

EID: 84858818947     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/664768     Document Type: Article

References (13)

1. Lee S, Kim Y, Chung DR. Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis. J Infect 2011;62:159-164.
2. Micek ST, Welch EC, Khan J, et al. Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with gram-negative bacteremia. J Hosp Med 2011;6: 405-410.
3. Zilberberg MD, Shorr AF, Micek ST, et al. Hospitalizations with heathcare-associated complicated skin and skin structure infections: impact of inappropriate empiric therapy on outcomes. J Hosp Med 2010;5:535-540.
4. Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 2010;54:4851-4863.
5. Fridkin SK, Edwards JR, Courval JM, et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med 2001;135:175-183.
6. Mauldin PD, Salgado CD, Hansen IS, Surup DT, Bosso JA. Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotics-resistant gram-negative bacteria. Antimicrob Agents Chemother 2010;54: 109-115.
7. Dellit TH, Owens RC, McGowan JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44: 159-177.
8. Christoff J, Tolentino J, Mawdsley E, Matushek S, Pitrak D, Weber SG. Optimizing empirical antimicrobial therapy for infection due to gram-negative pathogens in the intensive care unit: utility of a combination antibiogram. Infect Control Hosp Epidemiol 2010;31:256-261.
9. Fox B, Shenk G, Peterson D, Spiegel C, Maki D. Choosing more effective antimicrobial combinations for empiric antimicrobial therapy of serious gram-negative rod infections using a dual cross-table antibiogram. Am J Infect Control 2008;36:S57-S61.
10. Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arc Intern Med 2003;163:972-978.
11. Hindler JF, Stelling J. Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute. Clin Infect Dis 2007;44:867-873.
12. Jha AK, DesRoches CM, Kralovec PD, Joshi MS. A progress report on electronic health records in U.S. Hospitals. Health Aff (Milwood) 2010;29:1951-1957.
13. Department of Health and Human Services. Medicare and Medicaid programs; electronic health record incentive program; proposed rule. Fed Regist 2010;75:1844-2011.